IL6 and hepatocellular carcinoma: In summary, our work identifies hepatocyte CD44 as a key age-associated node coupling TICs to IL6/JAK/STAT3 activation and local T cell dysfunction, thereby linking features of the aging liver microenvironment to increased HCC risk.